- Krishna Ella, Chairman and Managing Director of Bharat Biotech, said the two vaccines were in an advanced stage of development and could be ready soon.
- He said they were ready to start animal tests soon.
- He hoped that the Indian government will move quickly to give approvals for the trials.
- Bharat Biotech filed patents for both candidates in July 2015, Dr. Ella said.
- Since the company had already worked on chikungunya, this was the next logical step.